A focused, accessible introduction to this key aspect of cancer biology. It covers the individual cell signalling pathways that are known to be involved in cancer development, and, most important, includes the cross- interactions between the pathways together with the current therapeutic approaches. This is a ‘must-have’ for advanced undergraduate and postgraduate students studying and researching within the field of cancer biology.
"synopsis" may belong to another edition of this title.
Dr Amanda Harvey, Brunel Institute for Cancer Genetics and Pharmacogenomics, Brunel University, Kingston Lane, Middlesex, UK.
As our understanding of tumour biology has developed, molecules involved in disrupting normal cell signalling and driving cells towards a more cancerous phenotype have provided the basis for new drug targets, and a number of targeted biological therapies now exist for the treatment of tumours. However, many cancer patients have tumours that are either refractory to treatment, or that develop resistance. The amount of research into this area has provided a wealth of information about cross-talk between signalling pathways and compensatory signalling.
The aim of this book is to introduce a number of cell signalling pathways that are both well characterised and reported to play central roles in the development of a number of different tumour types. Each chapter focuses on an individual pathway, its key components and dysregulation in tumour development, in the context of both current therapies and future strategies. The final chapter is devoted to signalling cross-talk. Interactions between signalling pathways, compensatory signalling and tumour related issues are presented so that the reader will not only develop a better appreciation for the role of signalling in disease, but also begin to understand the relevance of cross-talk.
Cancer Cell Signalling will prove invaluable for advanced undergraduates and postgraduates studying and researching within this fast moving and complex field.
As our understanding of tumour biology has developed, molecules involved in disrupting normal cell signalling and driving cells towards a more cancerous phenotype have provided the basis for new drug targets, and a number of targeted biological therapies now exist for the treatment of tumours. However, many cancer patients have tumours that are either refractory to treatment, or that develop resistance. The amount of research into this area has provided a wealth of information about cross-talk between signalling pathways and compensatory signalling.
The aim of this book is to introduce a number of cell signalling pathways that are both well characterised and reported to play central roles in the development of a number of different tumour types. Each chapter focuses on an individual pathway, its key components and dysregulation in tumour development, in the context of both current therapies and future strategies. The final chapter is devoted to signalling cross-talk. Interactions between signalling pathways, compensatory signalling and tumour related issues are presented so that the reader will not only develop a better appreciation for the role of signalling in disease, but also begin to understand the relevance of cross-talk.
Cancer Cell Signalling will prove invaluable for advanced undergraduates and postgraduates studying and researching within this fast moving and complex field.
"About this title" may belong to another edition of this title.
Seller: BooksRun, Philadelphia, PA, U.S.A.
Paperback. Condition: Very Good. 1. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting. Seller Inventory # 1119967570-8-1
Seller: Corner of a Foreign Field, Tokyo, TOKYO, Japan
Soft cover. Condition: Very Good. No Jacket. 1st Edition. 2013.Softcover.Very good condition.211 pages.Ships from Japan.Usually ships in 1-2 working days. Seller Inventory # 20233
Quantity: 1 available